Acella Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACELLA
ACELLA has thirteen approved drugs.
Summary for Acella
| US Patents: | 0 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 13 |
| Patent Litigation for Acella: | See patent lawsuits for Acella |
Drugs and US Patents for Acella
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acella | CICLOPIROX | ciclopirox | SOLUTION;TOPICAL | 078172-001 | Sep 18, 2007 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acella | LACOSAMIDE | lacosamide | SOLUTION;INTRAVENOUS | 218464-001 | Nov 14, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acella Pharms Llc | GABAPENTIN | gabapentin | SOLUTION;ORAL | 076403-001 | May 1, 2012 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acella | BENZONATATE | benzonatate | CAPSULE;ORAL | 091310-002 | Jan 16, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Acella | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 072781-001 | Jul 30, 1993 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acella | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 210664-001 | Mar 16, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

